Table 2. Correlation between ΔNp63 expression and histopathological findings and metastasis in TCC.
| ΔNp63 expression | |||||
|---|---|---|---|---|---|
| n | High n (%) |
Low n (%) |
p | ||
| Grade | 1–2 | 11 | 6 (54.5) | 5 (45.5) | 1 |
| 3 | 14 | 7 (50) | 7 (50) | ||
| Mitotic count | <10/50 HPFs | 14 | 9 (64.3) | 5 (36.4) | 0.238 |
| ≥10/50 HPFs | 11 | 4 (35.7) | 7 (63.6) | ||
| Necrosis | Absent | 14 | 9 (64.3) | 5 (35.7) | 0.238 |
| Present | 11 | 4 (36.4) | 7 (63.6) | ||
| Muscle invasion | Absent | 9 | 7 (77.8) | 2 (22.2) | 0.041 |
| Present | 16 | 5 (31.3) | 11 (68.7) | ||
| Vascular invasion | Absent | 8 | 8 (100) | 0 (0) | 0.002 |
| Present | 17 | 5 (29.4) | 12 (70.6) | ||
| Metastasisa | No | 15 | 11 (73.3) | 4 (26.7) | 0.015 |
| Present | 10 | 2 (20) | 8 (80) | ||
HPF: High-power field; TCC: Transitional cell carcinoma.
(a): Overall follow-up period.